Genpharmasec Ltd
₹1.11
(-0.89%)
Thu, 12 Mar 2026, 10:09 pm
Process Industries
Chemicals: Specialty
24.5KGenpharmasec Price to Cash Flow Ratio
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 1460 | 277.71 | 173.01 | 0 | 76.53 | 0 | 83.63 |
| Price to book ratio | 15.66 | 14.75 | 10.73 | 9.91 | 5.62 | 1.85 | 1.61 |
| Price to sales ratio | 902.10 | 17.02 | 10.20 | 5.57 | 3.37 | 2.25 | 3.10 |
| Price to cash flow ratio | 0 | 144.61 | 0 | 0 | 0 | 0 | 22.54 |
| Enterprise value | 3.32B | 2.76B | 2.06B | 1.48B | 862.39M | 520.19M | 1.05B |
| Enterprise value to EBITDA ratio | 0 | 422.37 | 172.57 | 0 | 335.17 | 1130 | 350.56 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0.20 | 0.06 | 0.08 |
| Return on equity % | 0 | 4.97 | 6.34 | -1.16 | 7.33 | -0.32 | 1.94 |
Genpharmasec Ltd Price to Cash Flow Ratio
The Genpharmasec Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Genpharmasec Ltd's valuation, profitability, and overall financial performance. Tracking the Genpharmasec Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Genpharmasec Ltd (NSE: , BSE: 531592) is currently trading at ₹1.11, with a market capitalization of ₹620.17M. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Genpharmasec Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Genpharmasec Ltd Price to Cash Flow Ratio Current Value
The current Genpharmasec Ltd Price to Cash Flow Ratio stands at 22.54.
The latest Genpharmasec Ltd Price to Cash Flow Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Genpharmasec Ltd Price to Cash Flow Ratio Historical Trend
The Genpharmasec Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 22.54
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The recent rise in Genpharmasec Ltd Price to Cash Flow Ratio suggests strengthening valuation trends and improving market sentiment.
What Genpharmasec Ltd Price to Cash Flow Ratio Indicates for Investors
The Genpharmasec Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Genpharmasec Ltd Price to Cash Flow Ratio Analysis Summary
The Genpharmasec Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Genpharmasec Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Genpharmasec Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
